Conversely, notwithstanding a considerable up-regulation in terms of whole intra-tumor CD4+ T cell frequency, a remarkable change in immunosuppressive CD4+FOXP3+ Tregs was not observed in response to olaparib by Pantelidou et al. [87]. This evidence concerns the gene CD4 and neoplasm.